Vaccines Archives | Report Store | Pharma intelligence

Pneumococcal Vaccines Market and Forecast Analysis to 2024

Streptococcus pneumoniae (S. pneumoniae) is a bacterium that can cause multiple types of pneumococcal disease, including bloodstream infections (sepsis), pneumonia, meningitis, and other milder diseases such as sinusitis and otitis media. The severity of pneumococcal disease is characterized as invasive or non-invasive, with invasive pneumococcal disease being more severe as the bacterium can be isolated from ordinarily sterile sites (eg blood or cerebrospinal fluid), and requires hospital treatment.

December 10, 2020

Find out more

Dengue Vaccines

Dengue fever is an emerging flaviviral infection transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes.

November 13, 2020

Find out more

Seasonal Influenza Vaccines

Seasonal influenza is an acute viral infection that is spread by person-to-person transmission. Influenza, commonly referred to as the flu, circulates worldwide and can affect anyone in any age group, although annual epidemics peak during winter in temperate climates.

October 30, 2020

Find out more

Meningococcal Vaccines Disease Coverage Forecast and Market Analysis to 2024

Meningitis is an infection of the meninges, the membranes surrounding the brain and spinal cord. It can be caused by a number of different viral and bacterial pathogens including Haemophilus influenzae b (Hib) and Streptococcus pneumoniae.

October 6, 2020

Find out more

Disease Analysis: Human Papillomavirus (HPV) Vaccines

Worldwide vaccination programs for human papillomavirus (HPV) have evolved substantially over the last decade.

October 5, 2020

Find out more

Disease Analysis: Respiratory Syncytial Virus (RSV) Prevention

Respiratory syncytial virus (RSV), a member of the Paramyxoviridae family, is an enveloped, non-segmented, single-stranded, negativesense RNA virus. It is a common respiratory virus that is the leading cause of bronchiolitis in infants, and is estimated to be responsible for 22% of all episodes of acute lower respiratory tract infections in young children. Almost all children are infected with RSV within the first two years of life, and approximately 0.5–2.0% of infections will result in hospitalization. RSV is also recognized as a major cause of morbidity in immunosuppressed adults and the elderly, with an estimated 177,000 elderly people hospitalized and 14,000 dying annually in the US due to RSV infection

August 26, 2020

Find out more

Respiratory Syncytial Virus Vaccines

Respiratory syncytial virus (RSV) is an enveloped, non-segmented, single-stranded, negative-sense RNA virus belonging to the Paramyxoviridae family.

October 5, 2018

Find out more

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interviews

$599.00

Datamonitor Healthcare interviewed two infectious disease experts, one based in the US and one in France, to gauge their views on the seasonal influenza vaccines market, its outlook over the next five years and any key events that are likely to take place, including the impact of novel quadrivalent inactivated influenza vaccines and other incremental advances

April 18, 2017

Find out more